News
The 25,000-square-foot center is opening with a staff of 35, but that number is expected to double over the next two years.
19hon MSNOpinion
In a world of increasing fragmentation and polarisation, the 78th World Health Assembly, starting Monday, will present itself ...
Health experts discussed ways to enhance the role of vaccinations in managing common chronic diseases in an ageing population ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad ...
The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax's COVID-19 vaccine, but only for certain ...
Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...
Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.
Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...
Nuvaxovid had been available under emergency use authorization but the full approval may allow it to better compete with ...
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could ...
The FDA has approved Novavax’s COVID-19 vaccine, Nuvavoxid, for use in adults 65 and older and in individuals ages 12-64 who have at least one underlying health condition. The approval is based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results